Records containing: Ulcerative Colitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-09-30A Double-blind Placebo-controlled Phase 1 Study to Evaluate the Safety and Efficacy of MB-001 in Single and Multiple Ascending Doses in Healthy Human Participants
-
CLINICAL_TRIALS study record update · 2025-09-30A Multicenter, Phase 3b, Open-Label, Single-Arm Study to Investigate Bowel Urgency and Its Relationship With Other Outcome Measures in Adults With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab
-
CLINICAL_TRIALS study record update · 2025-09-30A Multicenter, Phase 3b, Open-Label, Single-Arm Study to Investigate Bowel Urgency and Its Relationship With Other Outcome Measures in Adults With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab
-
CLINICAL_TRIALS study record update · 2025-09-24Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases: The SECURITY Trial
-
CLINICAL_TRIALS study record update · 2025-09-19An Open-Label, Phase 3 Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of Vedolizumab Subcutaneous in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-09-18A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam BID for 2 Weeks, Followed by QD for 4 Weeks, in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2025-09-18Evaluation of Microbiota and Probiotic Therapy in Ulcerative Colitis Patients
-
CLINICAL_TRIALS study record update · 2025-09-16CP101 for the Treatment of Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2025-09-16A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets n Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2025-09-12Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2025-09-12Is Clostridioides Difficile Infection Associated With Changes in Bile Acid Profiles in Children With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2025-09-11Effects of a Fasting Mimicking Diet on Depressive Symptoms in Patients With Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2025-09-11Special Drug-Use Surveillance Study on Entyvio for IV Infusion 300 mg [Ulcerative Colitis]
-
CLINICAL_TRIALS study record update · 2025-09-09A Phase 2, Randomized, Double-Blinded, Placebo Controlled, Parallel Group Study Evaluating the Efficacy and Safety of Amiselimod (MT-1303) in Subjects With Mild to Moderate Ulcerative Colitis (UC)
-
CLINICAL_TRIALS study record update · 2025-09-04A Follow-up Phase II Open-label Study to Evaluate the Long-term Safety and Efficacy Profile of ABX464 Given at 25 mg Once Daily in Subjects With Moderate to Severe Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2025-09-02Prospective, Non-interventional, Observational Study in Patients With IBD Receiving IV or SC Vedolizumab Therapy to Observe Route of Administration Choices and Outcomes (VARIETY-POLAND)
-
CLINICAL_TRIALS study record update · 2025-08-29Rutin Therapy Reduces Ulcerative Colitis Disease Activity By Inhibiting The NOD-Like Receptor Protein 3 (NLRP3) Inflammasome: A Molecular Assessment in a Case-Control Study
-
CLINICAL_TRIALS study record update · 2025-08-28Self-Management Assistance for Recommended Treatement (SMART) App Randomized Control Trial
-
CLINICAL_TRIALS study record update · 2025-08-21A Phase 1, Open-label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis.
-
CLINICAL_TRIALS study record update · 2025-08-21Improving the Quality of Care for Adults With Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2025-08-19The Impact of Circadian Misalignment on Colonic Barrier Homeostasis in Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2025-08-13Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2025-08-11An Open-label Clinical Trial to Evaluate the Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2025-08-01Paediatric Inflammatory Bowel Diseases Network for Safety, Efficacy, Treatment and Quality Improvement of Care: The PIBD-NET Inception Cohort and Safety Registry
-
CLINICAL_TRIALS study record update · 2025-07-31MOdel-Informed Precision Dosing (MIPD) of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease - An Independent Randomized Controlled Trial